CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.25B, above the global median of $1.18B
- PositionP/E ratio is 148.33×, higher than 95% of its Medical Devices peers (median 27.26×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.12%
Annual Rate
CNY 0.02Paid unknown
Payout Ratio
16.9%Sustainable
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
8.34BCNY1.25B · vs all stocks (USD)
Trailing P/E
148.33xvs Medical Devices peers
Revenue (TTM)
516.03MCNY77.03M · vs all stocks (USD)
Profit Margin
11.34%vs Medical Devices peers
Beta
-0.3210xvs all stocks
52-Week Change
-21.13%vs all stocks
Forward Annual Dividend Yield
0.12%vs all stocks
Market Capitalization
8.34BCNY1.25B · vs all stocks (USD)
Enterprise Value
7.14BCNY1.07B · vs all stocks (USD)
Trailing P/E
148.33xvs Medical Devices peers
Forward P/E
104.07xvs Medical Devices peers
Price to Sales (TTM)
16.23xvs Medical Devices peers
Price to Book (MRQ)
4.62xvs Medical Devices peers
Enterprise to Revenue
13.84xvs Medical Devices peers
Enterprise to EBITDA
169.76xvs Medical Devices peers
Gross Margin
55.75%vs Medical Devices peers
Profit Margin
11.34%vs Medical Devices peers
Operating Margin
2.59%vs Medical Devices peers
Return on Assets (TTM)
0.29%vs Medical Devices peers
Return on Equity (TTM)
3.26%vs Medical Devices peers
Revenue (TTM)
516.03MCNY77.03M · vs all stocks (USD)
Revenue per Share (TTM)
1.10CNYUpdated Sep 22, 2026Quarterly Revenue Growth
24.80%vs Medical Devices peers
Gross Profit (TTM)
284.03MCNY42.40M · vs all stocks (USD)
EBITDA (TTM)
63.38MCNY9.46M · vs all stocks (USD)
Net Income (TTM)
58.50MCNY8.73M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-25.70%vs Medical Devices peers
Operating Cash Flow (TTM)
27.77MCNY4.14M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-41.90MCNY-6.25M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0200CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.12%vs all stocks
Trailing Annual Dividend Rate
0.0210CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.12%vs all stocks
Payout Ratio
16.89%vs Medical Devices peers
Revenue
464.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
195.22MCNYFY2025 · Dec 31, 2025Gross Profit
269.31MCNYFY2025 · Dec 31, 2025Operating Income
39.02MCNY5.83M · vs all stocks (USD)
Pre-tax Income
51.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
260.59KCNYFY2025 · Dec 31, 2025Net Income
51.08MCNYFY2025 · Dec 31, 2025EBIT
51.64MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
84.36MCNYFY2025 · Dec 31, 2025Research & Development
64.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
71.19MCNYFY2025 · Dec 31, 2025Other Operating Expenses
3.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
300.07KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1085CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1085CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
470.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
470.80MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.08MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
5.99MCNYFY2025 · Dec 31, 2025Free Cash Flow
-116.24MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
276.52MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.08MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
117.46KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-48.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-122.23MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.88BCNYFY2025 · Dec 31, 2025Sale of Investments
4.92BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-77.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-5.08MCNYFY2025 · Dec 31, 2025Shares Outstanding
470.60MSharesUpdated Sep 22, 2026Float Shares
115.09MSharesUpdated Sep 22, 2026% Held by Insiders
40.04%vs all stocks
% Held by Institutions
39.24%vs all stocks
Total Cash (MRQ)
1.24BCNY184.88M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.63CNYUpdated Sep 22, 2026Total Debt (MRQ)
4.74MCNY707.69K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0026xvs Medical Devices peers
Current Ratio (MRQ)
8.36xvs Medical Devices peers
Book Value per Share (MRQ)
3.85CNYUpdated Sep 22, 2026Total Assets
1.99BCNY297.50M · vs all stocks (USD)
Total Current Assets
1.55BCNYFY2025 · Dec 31, 2025Total Liabilities
190.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
440.08MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
32.09MCNYFY2025 · Dec 31, 2025Total Current Liabilities
158.87MCNYFY2025 · Dec 31, 2025Cash
276.52MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
276.52MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.03BCNYFY2025 · Dec 31, 2025Accounts Receivable
77.99MCNYFY2025 · Dec 31, 2025Inventory
159.37MCNYFY2025 · Dec 31, 2025Accounts Payable
89.94MCNYFY2025 · Dec 31, 2025Short-term Debt
4.08MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.01MCNYFY2025 · Dec 31, 2025Long-term Debt
559.65KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.35MCNYFY2025 · Dec 31, 2025Common Stock (Book)
470.60MCNYFY2025 · Dec 31, 2025Retained Earnings
48.23MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY269.00M · vs all stocks (USD)
52-Week Low
16.38CNYUpdated Sep 22, 202652-Week High
28.26CNYUpdated Sep 22, 202652-Week Change
-21.13%vs all stocks
Beta
-0.3210xvs all stocks
50-Day MA
19.38CNYUpdated Sep 22, 2026200-Day MA
22.73CNYUpdated Sep 22, 2026Avg 10-Day Volume
3.18MSharesUpdated Sep 22, 2026Avg 30-Day Volume
4.74MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1200CNYUpdated Sep 22, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 148.33×, higher than 95% of its Medical Devices peers (median 27.26×)Significant
P/E ratio: 148.333Industry median: 27.26Industry P95: 90.04Peers compared: 60.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 8,732,212.603Operating Cash Flow (USD, TTM): 4,144,731.727
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.25B, above the global median of $1.18BNotable
Market cap (USD): 1,245,469,771.26Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Sun-Novo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Celltrion Pharm, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kissei Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Harrow Inc.
Tier 1ProductionApproval-Gated PipelineRule
Integra LifeSciences Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Changzhou Qianhong Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cronos Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Xianju Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Lukang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Carsgen Therapeutics Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Xiamen Solex High-Tech Industries Co., Ltd.
5 interpretationsMinimal Tax and Interest DragPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Shanghai Hajime Advanced Materials Co., Ltd.
5 interpretationsDebt Falling While Share Count RisesPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Idaho Strategic Resources, Inc.
4 interpretationsMinimal Tax and Interest DragPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration